Venky's turns profitable YoY on poultry recovery, but oilseed crash cuts PAT 71% QoQ
revenue +33.11% · margins compressing
₹1,066.01 Cr
+33.11% YoY
₹14.61 Cr
1.36%
+4.6pp YoY
₹10.37
Venky's (India) reported standalone revenue of ₹1,066.01 Cr and net profit of ₹14.61 Cr for Q2 FY27 (quarter ended 30 September 2026) — audited, standalone only, as no consolidated statement appears in this filing. On a year-on-year basis this is a turnaround: the company had posted a ₹26.53 Cr net loss in Q2 FY26, and revenue is up 33.1% YoY. But the YoY comparison flatters against an unusually weak base — the company's own notes describe Q2 as poultry's seasonal off-season, and Q2 FY26 was additionally hit by a feed-cost spike. Against the immediately preceding quarter the picture is weaker: revenue fell 4.7% QoQ from ₹1,118.38 Cr and PAT dropped 70.8% QoQ from ₹49.99 Cr, with EPS down to ₹10.37 from ₹35.49.
Q2 FY-2027 vs prior quarters
The sequential slide traces almost entirely to the Oilseed segment, whose profit before interest collapsed to ₹0.86 Cr from ₹30.96 Cr in Q1 FY27 and ₹10.18 Cr a year ago — management attributes this to volatile/high soya seed prices and weaker realisations on de-oiled cake sales. Animal Health Products, the segment management had guided toward double-digit growth, instead saw profit fall 15.4% YoY and 23.9% QoQ to ₹23.06 Cr on revenue growth of just 8.0% YoY. Poultry was the one bright spot, swinging to a ₹10.12 Cr segment profit from a ₹58.31 Cr loss a year ago on better realisations and operational efficiency, though even here profit eased from ₹16.25 Cr in Q1. The combined effect pulled margins down: OPM fell to 2.12% from 6.18% in Q1 FY27, and NPM to 1.36% from 4.42%, even as both remain well above the negative readings of Q2 FY26.
The stock went into the print at ₹1,610.6, down 5.4% over the past month of trading.
Management projects continued growth across all segments, with Animal Health Products and Oil Seed expected to be key drivers. While poultry segment performance is anticipated to be consistent year-on-year, it may exhibit some seasonal variations. The company is focused on increasing external sales in the Oil Seed segm
— This quarter: missed
No third-party Q2-specific consensus estimate for Venky's could be verified for this print. Our own pre-result preview had flagged oilseed volume/margin hold and AHP performance as two of three watch items for this quarter, alongside poultry realisations — both flagged risks materialised: oilseed margins did not hold, and AHP missed the 'double-digit growth' management guided for at the Q4 FY26 concall. Against that guidance — poultry consistent YoY, AHP double-digit growth, oilseed to maintain/improve performance — only poultry delivered; AHP and Oilseed both missed. Management's own filing notes largely confirm the numbers, except its characterisation of AHP's performance as 'satisfactory' despite the quarter's double-digit YoY and QoQ profit decline there.
W1
Oilseed segment EBIT was just ₹0.86 Cr this quarter on high soya costs — watch whether realisations normalise in Q3 FY27
W2
AHP profit fell YoY/QoQ this quarter versus management's guided double-digit growth — watch if H2 FY27 reaccelerates toward that bar
W3
Poultry segment profit eased sequentially to ₹10.12 Cr from ₹16.25 Cr in Q1 — watch whether the YoY turnaround holds into the seasonally stronger Q3
Standalone only — filing has no consolidated statement; totalIncome, PBT and PAT all tie out exactly to the rupee; no exceptional items or minority interest; figures converted from ₹ Lakh to ₹ Cr (÷100).
Poultry and oilseed momentum tested: Q2 shapes the full-year arc
After a strong Q1 recovery, Venky's Q2 print will signal whether the poultry bounce and oilseed surge are sustainable or normalize. Street expects double-digit PAT growth for the full year.
The setup: poultry, oilseed, and the full-year print
Venky's Q2 FY27 (quarter ended 30 September 2026) will land at a critical juncture. Q1 delivered a standout recovery—revenue ₹1,118 Cr (up 29% YoY), and profit after tax tripled YoY to ₹50 Cr—driven by a sharp reversal in poultry realizations and the oilseed business surging on volume and margin uptick. The question: does Q2 extend that momentum or normalize? Broiler pricing has held above cost of production since late October (guided through March); oilseed utilization sits near the company's 80% FY27 target. If both hold, Q2 should track on guidance. If either softens, the full-year arc shifts.
What to expect
~₹1,100–1,150 Cr
Q1 was ₹1,118 Cr; modest normalization expected but still tracking guidance
Positive, sustained
Management flagged profitable pricing through H2 FY27; the key swing for full-year PAT growth
~2.5–3.5%
Guided around 3% for the year; volume-dependent, limited upside unless soybean prices spike
Double-digit growth
Management guidance for FY27; new product launches and Kesavadi facility ramp
15–20% growth YoY
Analyst consensus for full year; Q2 validates whether this is tracking
A strong Q2 would confirm: poultry is sustainably profitable (not a temporary bounce), oilseed has found a volume/margin equilibrium, and AHP is delivering on growth targets. Margins broadly stable and PAT tracking the analyst guide. A weak Q2 would raise questions: poultry pricing is reversing earlier than expected, oilseed volumes are cooling, or one-time tailwinds in Q1 are unwinding. Either read would shift the full-year narrative and analyst consensus.
Street consensus
Since last quarter: board, filings, and a notable ownership shift
Board meeting scheduled for 13 November 2026 to approve Q2 FY27 and H1 FY27 audited results. No material corporate actions since Q1 FY27 release. A significant shift: promoter shareholding dropped from 56.11% historically to 0.00% in Q1 FY27 filings (FII +0.13pp to 1.27%, DII flat at 0.14%). This is unusual and warrants watching for any pledges or holding restructure disclosures; no insider trading or pledging alerts flagged in recent filings.
1 · Poultry realization trajectory
Management's commentary on broiler pricing sustainability through December and January. If realized rates are holding above cost of production and volumes are steady, the full-year guide for double-digit PAT growth is on track.
2 · Oilseed volume and margin hold
Q2 utilization rate vs. 80% FY27 target; EBIT margin vs. 3% base case. Any downside here (demand softening, soybean prices collapsing) would pressure the full-year guidance and Street confidence.
3 · AHP segment performance
Revenue run-rate and margin for animal health products. Guidance calls for double-digit growth and Kesavadi facility ramp; if tracking, it reinforces the Street's confidence in FY27 delivery. If lagging, it raises execution risk.
Venky's Q2 FY27 print is the litmus test for the full-year outlook. Q1's recovery in poultry and oilseed spike raised the bar for expectations; Q2 will confirm whether that's the new normal or a blip. The Street is priced for double-digit PAT growth and stable margins. Watch poultry realizations, oilseed utilization, and AHP execution. If all three track, the ₹2,270 target looks reasonable; if any one softens materially, consensus may compress.